Exco Intouch has announced that it will co-host two seminars examining the impact new technology has had on patient engagement in clinical trials.
The first event will be held at the Marriott Downtown, Philadelphia, US, on 21 April 2009.
A UK event will follow on 13 May at the Cumberland Hotel in London.
The seminar series is also being led by ERT, a provider of centralised ECG and e-clinical technology, and services to the biopharmaceutical, medical device and related industries.
The half-day seminars, entitled 'The Complete Patient Experience Throughout the Trial Lifecycle', will feature interactive discussions led by key industry figures.
Exco Intouch chief executive Tim Davis will examine the issues of mobile phone technology, security and patient confidentiality, plus the future of new clinical trial technologies.
Exco will also share several real-world retention and Epro case studies to demonstrate the benefits of mobile phone technology for use in clinical trials.
Exco Intouch representatives will be on hand to give an overview of how the company is harnessing the power of a patient's own mobile phone to deliver e-diaries - an alternative to other methods of data collection.
Ken Kaitin, director and professor of medicine, Tufts Center for the Study of Drug Development at TUFTS University in Massachusetts, will deliver a keynote address at both seminars entitled 'Pharmaceutical Innovation at a Crossroads: Economic and Political Perspectives on the New Drug Development Process'.
Other speakers at the event will include John H Greist, director at Healthcare Technology Systems, who will be discussing interactive voice response technology in suicidality assessments.
Exco Intouch's mobile-phone-based electronic patient reported outcomes (Epro), recruitment, retention and compliance offerings are already being used by large pharmaceutical companies to enhance clinical trial communications and improve data capture.
